Humacyte (HUMA) Beginning Cash Balance (2021)

Humacyte (HUMA) reported Beginning Cash Balance of $7172.0 for Q2 2021, down 94.9% quarter-over-quarter from $140591.0 in Q1 2021.

Humacyte (HUMA) Beginning Cash Balance (2021) Analysis & Trends

Humacyte (HUMA) has 1 years of Beginning Cash Balance data on file, last reported at $7172.0 in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Humacyte	183.21 Mn	134.67 Mn	-1.54 Mn

Download Data